Lead Labs was founded by Dr. Elizabeth A Frank, an internationally respected name in Lab Medicine, with a sharp focus on enabling high-quality diagnosis in both routine and specialised testing. The team of doctors and technical staff at Lead Labs maintain strict internal and external quality standards, following the guidelines prescribed by ISO 15189.
Lead Labs is a patient-centric standalone diagnostic lab focused on providing accurate diagnosis for everyone. We strongly recognise the fact that clinicians rely on laboratory reports for diagnosis, treatment, and follow up. Our paramount focus and vision is therefore to provide high-quality testing and reports.
Dr. Elizabeth A Frank is the driving force behind Lead Labs. She was the first clinical biochemist in Mysore to introduce a variety of specialised tests with quick turnaround times. She is an internationally well-known leader and speaker on lab medicine. She is a laboratory medicine specialist from Kasturba Medical College, Mangalore, and a postdoctoratal fellow of Louisville School of Medicine, Kentucky, and Emory Atlanta. Dr. Elizabeth A Frank has been involved in many research projects, some of which are as follows:
- Modification of Lipoproteins in cardiovascular disease.
- Lack of correlation of PON1 activity with smoking among south Indians and risk of cardiovascular disease.
- Oxidative inactivation of Paraoxanse – implications in diabetes mellitus and artheroscelosis.
- Development of new cardiac markers.
- C-Peptide as a marker for insulin resistance
- Microabuminuria in Diabetes
- Serum electrolyte profile and acid base balance in Diabetic Ketoacidosis
- Prevalence of Impaired Glucose Tolerance and Diabetes in first degree relatives of diabetic subjects by stress.
- Lipid abnormalities in NIDDM.
- Stratification of abnormalities in lipid profile in alcoholics.
- Prevalence of tuberculosis in HIV seropositive subjects.
- Elucidation of active principles in ayurvedic anti diabetic drugs by in vitro and vivo methods.
- Evaluation of drug resistance in patients with pulmonary tuberculosis.
- Glucotoxicity and beta cell protection
- Criteria for drug resistance in malaria using QBC